Combination of radiotherapy and targeted therapy for HER2-positive breast cancer brain metastases

被引：0
作者：
Xiaojing Yang
Hanru Ren
Yi Xu
Xue Peng
Wenxi Yu
Zan Shen
机构：
[1] Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Department of Oncology
[2] Shanghai Pudong Hospital,Department of Orthopedics, Pudong Medical Center
[3] Fudan University,Department of Radiation Oncology
[4] Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Department of Breast Surgery
[5] Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,undefined
来源：
European Journal of Medical Research | / 28卷
关键词：
Breast cancer; Human epidermal growth factor receptor 2; Brain metastasis; Radiation therapy; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Radiotherapy and targeted therapy are essential treatments for patients with brain metastases from human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, the combination of radiotherapy and targeted therapy still needs to be investigated, and neurotoxicity induced by radiotherapy for brain metastases has also become an important issue of clinical concern. It remained unclear how to achieve the balance of efficacy and toxicity with the application of new radiotherapy techniques and new targeted therapy drugs. This article reviews the benefits and potential risk of combining radiotherapy and targeted therapy for HER2-positive breast cancer with brain metastases.
引用
收藏
相关论文
共 996 条
  • [1] Bailleux C(2021)Treatment strategies for breast cancer brain metastases Br J Cancer 124 142-155
  • [2] Eberst L(2019)Outcome of Omani women with breast cancer-associated brain metastases experience from a University Hospital Oman Med J 34 412-419
  • [3] Bachelot T(2020)Brain malignancies: glioblastoma and brain metastases Semin Cancer Biol 60 262-273
  • [4] Zahid KF(2020)Treating brain metastases from breast cancer: outcomes after stereotactic radiosurgery Clin Oncol (R Coll Radiol) 32 390-396
  • [5] Kumar S(2021)Use of radiotherapy in breast cancer patients with brain metastases: a retrospective 11-year single center study J Med Imaging Radiat Sci 52 214-222
  • [6] Al-Bimani K(2018)Whole-brain radiotherapy for brain metastases: evolution or revolution? J Clin Oncol 36 483-491
  • [7] Ahmed T(2022)Trastuzumab deruxtecan for HER2+ advanced breast cancer Future Oncol 18 7-19
  • [8] Al-Ajmi A(2020)Molecular and cellular mechanisms underlying brain metastasis of breast cancer Cancer Metastasis Rev 39 711-720
  • [9] Burney IA(2021)HER2-positive metastatic breast cancer: a comprehensive review Clin Adv Hematol Oncol 19 40-50
  • [10] Al-Moundhri M(2022)Radiotherapy to the primary tumor: the first step of a tailored therapy in metastatic prostate cancer Diagnostics (Basel) 12 1981-752
12345678910